- Report
- July 2024
- 335 Pages
Global
From €4428EUR$4,950USD£3,893GBP
- Report
- April 2024
- 270 Pages
Global
From €4473EUR$5,000USD£3,933GBP
- Report
- February 2022
- 272 Pages
Global
From €5368EUR$6,000USD£4,719GBP
- Report
- January 2024
- 140 Pages
Global
From €2362EUR$2,640USD£2,076GBP
€2952EUR$3,300USD£2,596GBP
- Report
- October 2019
Global
From €2004EUR$2,240USD£1,762GBP
€2505EUR$2,800USD£2,202GBP
- Report
- October 2022
- 510 Pages
China
From €1718EUR$1,920USD£1,510GBP
€2147EUR$2,400USD£1,888GBP
- Report
- November 2024
- 240 Pages
Global
From €1718EUR$1,920USD£1,510GBP
€2147EUR$2,400USD£1,888GBP
- Report
- May 2024
- 420 Pages
Global
From €2147EUR$2,400USD£1,888GBP
€2684EUR$3,000USD£2,360GBP
- Report
- February 2024
- 50 Pages
Global
From €1718EUR$1,920USD£1,510GBP
€2147EUR$2,400USD£1,888GBP
- Report
- February 2022
- 360 Pages
United States
From €2576EUR$2,880USD£2,265GBP
€3221EUR$3,600USD£2,832GBP
- Report
- October 2021
- 78 Pages
Global
From €573EUR$640USD£503GBP
€716EUR$800USD£629GBP
- Report
- December 2023
- 220 Pages
Global
From €2362EUR$2,640USD£2,076GBP
€2952EUR$3,300USD£2,596GBP
- Report
- October 2023
- 420 Pages
Global
From €2075EUR$2,320USD£1,825GBP
€2594EUR$2,900USD£2,281GBP
- Report
- June 2022
- 1500 Pages
Global
From €2791EUR$3,120USD£2,454GBP
€3489EUR$3,900USD£3,067GBP
- Drug Pipelines
- May 2022
- 400 Pages
Global
From €2147EUR$2,400USD£1,888GBP
€2684EUR$3,000USD£2,360GBP
- Report
- November 2021
- 222 Pages
Global
From €2147EUR$2,400USD£1,888GBP
€2684EUR$3,000USD£2,360GBP
- Report
- September 2023
Global
From €4428EUR$4,950USD£3,893GBP
- Report
- January 2023
- 356 Pages
Global
From €4428EUR$4,950USD£3,893GBP
- Report
- July 2024
- 476 Pages
Global
From €4428EUR$4,950USD£3,893GBP
- Report
- March 2024
- 181 Pages
Global
From €2192EUR$2,450USD£1,927GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more